ArticleExperimental and therapeutic medicine2025
Clinical features and outcomes of thyroid hyalinizing trabecular tumors: An 11-year experience at a tertiary referral hospital.
Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyalinizing trabecular tumors (HTTs) of the thyroid are rare neoplasms that generally exhibit benign behavior, lacking capsular or vascular invasion. Despite this, HTTs often present histopathological features that closely resemble those of papillary thyroid carcinoma (PTC), posing an important diagnostic challenge and leading to the frequent misinterpretation of fine needle aspiration biopsy (FNAB) results as PTC. The present study aimed to investigate the clinical characteristics and outcomes of HTTs observed over 11 years at a tertiary referral hospital [Chonnam National University Hwasun Hospital (Hwasun, South Korea)]. A retrospective analysis was conducted on 11 patients with pathologically confirmed HTT, evaluated between March 2011 and December 2021, following their final histological examinations after surgery. Of the 9,169 patients who underwent thyroid surgery during this period, 11 patients (0.12%) were histologically diagnosed with HTT. FNAB was performed in 10 patients, but HTT was included in the differential diagnosis in only 1 patient, while 6 patients were suspected as PTC or unspecific carcinoma. The average tumor size measured by preoperative ultrasonography (US) was 1.7±1.1 cm (range, 0.3-3.9 cm). The majority of tumors appeared hypoechoic with well-defined margins, and no US features indicative of malignancy were observed. Surgical management included thyroid lobectomy in 6 patients and total thyroidectomy in 5 patients. Over a mean follow-up period of 38 months, no recurrences or metastases were observed. In summary, these findings highlight the limited diagnostic utility of FNAB or US in the preoperative identification of HTTs. In cases where preoperative US findings are benign and FNAB results suggest PTC, HTT should be considered in the differential diagnosis to avoid overtreatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.